Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor

Introduction: Several circulating markers, including autoantibodies to erythropoietin receptor (anti-EPOR antibodies), have been identified as useful biomarkers in predicting diabetic kidney disease progression. However, a direct comparison of their utility is lacking. We aimed to validate and to co...

Full description

Bibliographic Details
Main Authors: Megumi Oshima, Akinori Hara, Tadashi Toyama, Min Jun, Carol Pollock, Meg Jardine, Stephen Harrap, Neil Poulter, Mark E. Cooper, Mark Woodward, John Chalmers, Vlado Perkovic, Muh Geot Wong, Takashi Wada
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Kidney International Reports
Subjects:
biomarker
end-stage kidney disease
type 2 diabetes
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024920317101

Internet

http://www.sciencedirect.com/science/article/pii/S2468024920317101

Similar Items